184 related articles for article (PubMed ID: 28867665)
1. Pharmacogenomic Variability of Oral Baclofen Clearance and Clinical Response in Children With Cerebral Palsy.
McLaughlin MJ; He Y; Brunstrom-Hernandez J; Thio LL; Carleton BC; Ross CJD; Gaedigk A; Lewandowski A; Dai H; Jusko WJ; Leeder JS
PM R; 2018 Mar; 10(3):235-243. PubMed ID: 28867665
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of oral baclofen in pediatric patients with cerebral palsy.
He Y; Brunstrom-Hernandez JE; Thio LL; Lackey S; Gaebler-Spira D; Kuroda MM; Stashinko E; Hoon AH; Vargus-Adams J; Stevenson RD; Lowenhaupt S; McLaughlin JF; Christensen A; Dosa NP; Butler M; Schwabe A; Lopez C; Roge D; Kennedy D; Tilton A; Krach LE; Lewandowski A; Dai H; Gaedigk A; Leeder JS; Jusko WJ
J Pediatr; 2014 May; 164(5):1181-1188.e8. PubMed ID: 24607242
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Oral Baclofen in the Treatment of Spasticity in Children and Adolescents With Cerebral Palsy.
Navarrete-Opazo AA; Gonzalez W; Nahuelhual P
Arch Phys Med Rehabil; 2016 Apr; 97(4):604-618. PubMed ID: 26321489
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial.
Gilmartin R; Bruce D; Storrs BB; Abbott R; Krach L; Ward J; Bloom K; Brooks WH; Johnson DL; Madsen JR; McLaughlin JF; Nadell J
J Child Neurol; 2000 Feb; 15(2):71-7. PubMed ID: 10695888
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
Dai AI; Wasay M; Awan S
J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
[TBL] [Abstract][Full Text] [Related]
6. Long-term therapy with intrathecal baclofen improves quality of life in children with severe spastic cerebral palsy.
Kraus T; Gegenleitner K; Svehlik M; Novak M; Steinwender G; Singer G
Eur J Paediatr Neurol; 2017 May; 21(3):565-569. PubMed ID: 28237420
[TBL] [Abstract][Full Text] [Related]
7. Continuous intrathecal baclofen infusion for children with cerebral palsy: a pilot study.
Scheinberg A; O'Flaherty S; Chaseling R; Dexter M
J Paediatr Child Health; 2001 Jun; 37(3):283-8. PubMed ID: 11468046
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy: a randomised controlled trial.
Hoving MA; van Raak EP; Spincemaille GH; Palmans LJ; Becher JG; Vles JS;
Eur J Paediatr Neurol; 2009 May; 13(3):240-6. PubMed ID: 18595749
[TBL] [Abstract][Full Text] [Related]
9. Variability of Steady State Oral Baclofen Prescribing Practices in Pediatric Patients With Cerebral Palsy.
McLaughlin MJ; Ratnasingam D; McGhee E
Am J Phys Med Rehabil; 2020 May; 99(5):441-443. PubMed ID: 31688017
[TBL] [Abstract][Full Text] [Related]
10. Oral baclofen in children with cerebral palsy: a double-blind cross-over pilot study.
Scheinberg A; Hall K; Lam LT; O'Flaherty S
J Paediatr Child Health; 2006 Nov; 42(11):715-20. PubMed ID: 17044900
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal baclofen therapy in children with cerebral palsy: efficacy and complications.
Murphy NA; Irwin MC; Hoff C
Arch Phys Med Rehabil; 2002 Dec; 83(12):1721-5. PubMed ID: 12474176
[TBL] [Abstract][Full Text] [Related]
12. Epilepsy and intrathecal baclofen therapy in children with cerebral palsy.
Buonaguro V; Scelsa B; Curci D; Monforte S; Iuorno T; Motta F
Pediatr Neurol; 2005 Aug; 33(2):110-3. PubMed ID: 16087055
[TBL] [Abstract][Full Text] [Related]
13. Continuous intrathecal baclofen therapy in children with cerebral palsy - when does improvement emerge?
Ramstad K; Jahnsen R; Lofterod B; Skjeldal OH
Acta Paediatr; 2010 Nov; 99(11):1661-5. PubMed ID: 19912148
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal baclofen infusion for ambulant children with cerebral palsy.
Brochard S; Remy-Neris O; Filipetti P; Bussel B
Pediatr Neurol; 2009 Apr; 40(4):265-70. PubMed ID: 19302938
[TBL] [Abstract][Full Text] [Related]
15. 'Effects of oral baclofen on children with cerebral palsy'.
Vargus-Adams JN; Michaud LJ; Kinnett DG; McMahon MA; Cook FE
Dev Med Child Neurol; 2004 Nov; 46(11):787. PubMed ID: 15540642
[No Abstract] [Full Text] [Related]
16. Long-term follow-up on continuous intrathecal Baclofen therapy in non-ambulant children with intractable spastic Cerebral Palsy.
Vles GF; Soudant DL; Hoving MA; Vermeulen RJ; Bonouvrié LA; van Oostenbrugge RJ; Vles JS
Eur J Paediatr Neurol; 2013 Nov; 17(6):639-44. PubMed ID: 23871360
[TBL] [Abstract][Full Text] [Related]
17. The impact of intrathecal baclofen on the natural history of scoliosis in cerebral palsy.
Shilt JS; Lai LP; Cabrera MN; Frino J; Smith BP
J Pediatr Orthop; 2008 Sep; 28(6):684-7. PubMed ID: 18724209
[TBL] [Abstract][Full Text] [Related]
18. The role of intrathecal baclofen in the management of primary and secondary dystonia in children.
Woon K; Tsegaye M; Vloeberghs MH
Br J Neurosurg; 2007 Aug; 21(4):355-8. PubMed ID: 17676454
[TBL] [Abstract][Full Text] [Related]
19. The effect of continuous intrathecal baclofen therapy on ambulatory children with cerebral palsy.
Pruszczynski B; Sees J; Hulbert R; Church C; Henley J; Niiler T; Miller F
J Pediatr Orthop B; 2018 May; 27(3):214-220. PubMed ID: 28379909
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Efficacy and Side Effects of Oral Baclofen Versus Tizanidine Therapy with Adjuvant Botulinum Toxin Type A in Children With Cerebral Palsy and Spastic Equinus Foot Deformity.
Dai AI; Aksoy SN; Demiryürek AT
J Child Neurol; 2016 Feb; 31(2):184-9. PubMed ID: 25999301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
